| Spatial genomic heterogeneity within localized, multifocal prostate cancer PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ... Nature genetics 47 (7), 736-745, 2015 | 355 | 2015 |
| Predicting outcomes in radiation oncology—multifactorial decision support systems P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ... Nature reviews Clinical oncology 10 (1), 27, 2013 | 334 | 2013 |
| Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 1-13, 2014 | 170 | 2014 |
| Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 1-13, 2014 | 170 | 2014 |
| How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ... Mutation Research/Reviews in Mutation Research 764, 16-30, 2015 | 153 | 2015 |
| The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung … P Lambin, SF Petit, HJWL Aerts, WJC van Elmpt, CJG Oberije, ... Radiotherapy and oncology 96 (2), 145-152, 2010 | 81 | 2010 |
| Impact of supervised gene signatures of early hypoxia on patient survival R Seigneuric, MHW Starmans, G Fung, B Krishnapuram, DSA Nuyten, ... Radiotherapy and oncology 83 (3), 374-382, 2007 | 66 | 2007 |
| Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types MHW Starmans, B Krishnapuram, H Steck, H Horlings, DSA Nuyten, ... British journal of cancer 99 (11), 1884-1890, 2008 | 51 | 2008 |
| The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia MBE Schaaf, D Cojocari, TG Keulers, B Jutten, MH Starmans, MC de Jong, ... Radiotherapy and Oncology 108 (3), 529-534, 2013 | 48 | 2013 |
| The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer MHW Starmans, KC Chu, S Haider, F Nguyen, R Seigneuric, ... Radiotherapy and Oncology 102 (3), 436-443, 2012 | 47 | 2012 |
| Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors D Wang, NA Pham, J Tong, S Sakashita, G Allo, L Kim, N Yanagawa, ... International Journal of Cancer 140 (3), 662-673, 2017 | 45 | 2017 |
| A pilot study comparing HPV-positive and HPV-negative head and neck squamous cell carcinomas by whole exome sequencing AC Nichols, M Chan-Seng-Yue, J Yoo, W Xu, S Dhaliwal, J Basmaji, ... International Scholarly Research Notices 2012, 2012 | 42 | 2012 |
| Epigenetics in radiotherapy: Where are we heading? KM Smits, V Melotte, HEC Niessen, L Dubois, C Oberije, EGC Troost, ... Radiotherapy and Oncology 111 (2), 168-177, 2014 | 39 | 2014 |
| BPG: Seamless, automated and interactive visualization of scientific data C P’ng, J Green, LC Chong, D Waggott, SD Prokopec, M Shamsi, ... BMC bioinformatics 20 (1), 1-5, 2019 | 38 | 2019 |
| The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer T John, MHW Starmans, YT Chen, PA Russell, SA Barnett, SC White, ... PloS one 8 (7), e67876, 2013 | 37 | 2013 |
| Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ... Cancer medicine 2 (6), 916-924, 2013 | 33 | 2013 |
| Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ... Cancer Medicine 2 (6), 916-924, 2013 | 33 | 2013 |
| Systematic analysis of 18 F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors BAW Hoeben, MHW Starmans, RTH Leijenaar, LJ Dubois, ... BMC cancer 14 (1), 1-12, 2014 | 23 | 2014 |
| The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response MHW Starmans, D Zips, BG Wouters, M Baumann, P Lambin Radiotherapy and Oncology 92 (3), 417-422, 2009 | 23 | 2009 |
| Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences NS Fox, MHW Starmans, S Haider, P Lambin, PC Boutros BMC bioinformatics 15 (1), 1-14, 2014 | 21 | 2014 |
Philippe LambinProfessor of Precision Medicine, Maastricht UniversityEmail verificata su maastrichtuniversity.nl
